Impact of Cumulative Inflammation, Cardiac Risk Factors, and Medication Exposure on Coronary Atherosclerosis Progression in Rheumatoid Arthritis
ConclusionInflammation was a consistent and independent predictor of coronary atherosclerosis progression in RA. It should therefore be specifically targeted toward mitigating cardiovascular risk. Biologic disease ‐modifying antirheumatic drugs, statins, and BP control may further constrain plaque progression directly or indirectly.
Source: Arthritis and Rheumatology - Category: Rheumatology Authors: George A. Karpouzas,
Sarah R. Ormseth,
Elizabeth Hernandez,
Matthew J. Budoff Tags: Original Article Source Type: research
More News: Angiography | Arthritis | Calcium | Cardiology | Cardiovascular | Cholesterol | CT Scan | Eating Disorders & Weight Management | Heart | Obesity | Prednisone | Rheumatoid Arthritis | Rheumatology | Statin Therapy